Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-04-25 | He received a B.S. from Stanford University, a Master’s degree in molecular biology, and an M.D. and PhD from Albert Einstein College of Medicine. |
| 2019-04-16 | He received a B.S. from Stanford University, a Master’s degree in molecular biology, and an M.D. and PhD from Albert Einstein College of Medicine. |
| 2020-04-22 | He received a B.S. from Stanford University, a Master’s degree in molecular biology, and an M.D. and PhD from Albert Einstein College of Medicine. |
| 2021-04-21 | He received a B.S. from Stanford University, a Master’s degree in molecular biology, and an M.D. and PhD from Albert Einstein College of Medicine. |
| 2022-04-13 | He received a B.S. from Stanford University, a Masters degree in molecular biology, and an M.D. and PhD from Albert Einstein College of Medicine. |
| 2023-04-19 | Dr. Nisen held various roles at GlaxoSmithKline and Abbott Laboratories and has an M.D. and PhD from Albert Einstein College of Medicine. |
| 2024-04-16 | Dr. Nisen joined the Board of Directors in 2017... He received a B.S. from Stanford University, a Master’s degree in molecular biology, and an M.D. and PhD from Albert Einstein College of Medicine. |
Data sourced from SEC filings. Last updated: 2025-07-01